This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news

Filter

International Advisory Group launched

09 Jan 2017

As part of the Society’s charitable mission to promote and advance the spectrum of pharmacology, we are committed to fulfilling the needs of our members regardless of geography – and the International Advisory Group will play an important role in supporting this.

New winners of prizes and awards announced

06 Jan 2017

Congratulations to the winners of the Society's prizes and awards judged and/or announced during our annual meeting Pharmacology 2016.

BJCP article: Acid suppression medications linked to serious gastrointestinal infections

05 Jan 2017

In a population-based study from Scotland, use of commonly-prescribed acid suppression medications such as proton pump inhibitors (PPIs) was linked with an increased risk of intestinal infections.

Pharmacology mentioned in House of Common's debate on exiting the EU

20 Dec 2016

The Society is pleased to report that its evidence on the impact of exiting the European Union (EU) was highlighted during a House of Commons debate on 19 December 2016. This followed our ongoing engagement activity with MPs with a special interest in science and health, including our written submission on "Leaving the EU" to the recent inquiry by the House of Commons' Science & Technology Committee.

BJCP article: Efforts Are Needed to Optimize the Use of Biologics for Treating Patients with Rheumatoid Arthritis

19 Dec 2016

The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.

New Honorary Fellows & Fellows announced

14 Dec 2016

Contributions across pharmacology and related fields honoured.

'Next generation' precision medicine for cystic fibrosis wins prestigeous drug discovery award

14 Dec 2016

A new medicine to treat cystic fibrosis has received Drug Discovery of the Year 2017, a prestigious award from the British Pharmacological Society. A combination of two drugs (lumacaftor and ivacaftor) offers a significant step forward for the treatment of this life-limiting, inherited disease. The award is made to the team of researchers at pharmaceutical company Vertex Pharmaceuticals, which is responsible for the development of lumacaftor/ivacaftor, in recognition of the drug offering an innovative approach that addresses a significant unmet medical need.

BJCP article: Greater efforts are needed to encourage patients to report adverse drug reactions

21 Nov 2016

A review in the British Journal of Clinical Pharmacology examined published studies addressing patients’ perceptions and factors influencing their reporting of adverse drug reactions and found that most patients were not aware of reporting systems and others were confused about reporting.

2016 Hall of Fame honours inspirational pharmacologists from around the world

17 Nov 2016

The British Pharmacological Society today announced that its 3,500+ members from around the world voted to induct five influential pharmacologists into its Pharmacology Hall of Fame.

Professor Norman Bowery (1944–2016)

11 Nov 2016

The Society is sad to report that Professor Norman Bowery died on 25 October.

The Society's response to TrialsTracker

08 Nov 2016

Professor David Webb, President of the British Pharmacological Society, responds to TrialsTracker's data that many organisations in industry and academia are not sharing the results of their clinical trials.